Aging is the primary risk factor for neurodegenerative diseases (NDs), such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. The aging process is associated with cellular and molecular changes that can contribute to the onset and progression of neurodegenerative conditions. In recent years, there has been a surge in research and development (R&D) efforts to understand the underlying pathogenesis, identify potential biomarkers, and develop and discover drugs for aging-related NDs.
CD BioSciences offers a wide range of specialized services tailored to address the unique challenges posed by aging-related NDs. We help our clients unravel the pathogenesis of aging-related NDs. Our comprehensive capabilities also encompass various stages of the drug development process, from early target identification to preclinical efficacy and safety assessments.